Core Semantic Systems TMS
Launched by UNIVERSITY OF SOUTH CAROLINA · Mar 5, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Core Semantic Systems TMS trial is a research study that looks at how the brain processes words and language in people who are not affected by neurological conditions. Researchers will use a technique called Transcranial Magnetic Stimulation (TMS) to see how the left anterior temporal lobe, an area of the brain involved in understanding language, becomes active when people think about words.
To participate in this study, you need to be between 18 and 40 years old and a native English speaker. However, if you have a history of dementia, alcohol abuse, or certain psychiatric or neurological disorders, or if you’ve had a serious head injury or have significant vision or hearing problems, you may not be eligible. The study is currently looking for participants, and if you join, you can expect to engage in tasks that help researchers learn more about how our brains work when we use language.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be within the ages of 18 to 40
- • Native speakers of English
- Exclusion Criteria:
- • Potential participants with a clinically reported history of dementia, alcohol abuse, psychiatric or neurological disorders, traumatic brain injury, or extensive vision or hearing problems that prevents them from performing the tasks
- • Contraindication to TMS, determined by a standard TMS screening form
- • Contraindication to MRI, determined by a standard MRI screening form
- • Left handed participants
About University Of South Carolina
The University of South Carolina (USC) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and education, USC leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical investigations aimed at improving patient outcomes and addressing pressing health challenges. Collaborating with a diverse network of healthcare professionals, researchers, and community partners, USC fosters an environment of discovery and translation, ensuring that findings from clinical trials contribute significantly to the advancement of medical science and evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported